Whole Genome Sequencing Market - Current Impact to Make Big Changes by 2035
The research on ‘Whole Genome Sequencing Market’ presents a comprehensive evaluation of the current state of the industry and offers well-supported insights into its outlook through 2035. It reviews historical changes in the market size and provides a factual representation of how regional performance and industry trends have evolved. The report also offers a high-level understanding of key industry elements, including market dynamics, segmentation, and revenue estimation over the forecast timeline.

The global whole genome sequencing market size is estimated at USD 2.63 billion in 2025 and is poised to reach USD 13.62 billion by 2035; expected to grow at a CAGR of 17.9%. The forecast has been developed based on market behavior, existing product demand, and segment-wise performance. The study outlines operational considerations and challenges in the industry and presents a data-driven outlook for future growth without assigning qualitative assumptions.
source of information: https://www.rootsanalysis.com/....reports/whole-genome

How Roots Analysis Approaches Complex Pharmaceutical and Biotech Markets

Roots Analysis (https://www.rootsanalysis.com/)approaches these challenges through a research model that combines primary and secondary research with data analytics and analysis of technology evolution, R&D, commercial potential, regulation, regional dynamics, risks and opportunities. The organization describes this methodology as part of its broader market research and consulting activities.

Why Emerging Life-Sciences Markets Require Multiple Perspectives

Roots Analysis' Build Your Own Report(https://www.rootsanalysis.com/byor) model allows geographic scope to be defined across global and regional markets, while its research framework identifies regional growth drivers as one of the factors considered in market analysis.

Plasma Fractionation Market Estimated to Experience a Hike in Growth by 2035
A recently published research report on the Plasma Fractionation Market delivers a thorough analysis of historical trends and future projections till 2035. The article offers an overview of how the market has evolved in terms of size, structure, and geographic performance. It presents factual insights into how various regions and application areas have contributed to the overall expansion of this market in recent years.

The global plasma fractionation market valued at $ 5.3 billion in 2025 , is projected to reach $ 5.8 billion in 2026 and $ 12.7 billion by 2035 , representing a higher CAGR of 9.1% during the forecast period 2026 to 2035 . The research takes a grounded approach in presenting its findings, focusing on performance indicators across segments and territories without making speculative claims. Key developments, general industry behavior, and practical observations form the basis of the market forecast provided within this article.
Origin of Information: https://www.rootsanalysis.com/....reports/plasma-fract

Continuous Manufacturing Systems Market to Witness Promising Growth Opportunities by 2026-2035

I recently came across a report by Roots Analysis that really put things into perspective. According to them, the global continuous manufacturing systems market is estimated to grow from USD 378 million in 2025 to reach USD 483 million in 2026 and USD 1,750 million by 2035, representing a higher CAGR of 15.4% during the forecast period 2026 to 2035.

Reference: https://www.rootsanalysis.com/....reports/continuous-m

Continuous Manufacturing Systems Market Scope and Market Size:

Type of Molecule: Small molecule, biologic
Type of Equipment: Mixers, granulators, continuous bioreactor / reactors, others
Scale of Operation: Preclinical / clinical, commercial
Stage of Manufacturing: Upstream process, downstream process
Geography: North America, Europe, Asia Pacific

Amyotrophic Lateral Sclerosis Market - Current Impact to Make Big Changes by 2035
ALS Research Is Expanding the Search for New Treatment Approaches

A Diverse Treatment Pipeline Is Addressing an Unmet Need in ALS

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting motor neurons and leading to gradual loss of muscle function. Despite advances in understanding the disease, treatment options remain limited, creating continued demand for new therapeutic approaches.

The global ALS treatment market was valued at approximately USD 0.79 billion in 2024 and is projected to reach USD 1.38 billion by 2035, representing a CAGR of 5.2%.

Treatment strategies include medications, respiratory therapy, physical and speech therapy, supportive care and experimental approaches such as stem cell therapy.

Drug developers are investigating multiple mechanisms aimed at slowing disease progression or addressing specific biological pathways involved in ALS. Both sporadic and familial forms of the disease are being studied.
For more information on the Amyotrophic Lateral Sclerosis Treatment Market, visit:

https://www.rootsanalysis.com/....reports/amyotrophic-